Cargando…
Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease
Recently, there has been an increasing interest in the therapeutic efficacy of RAS inhibitors (RASi) in patients with non-alcoholic fatty liver disease (NAFLD) because they may reduce oxidative stress, inflammatory markers, and enhanced fibrosis. An objective of this study was to investigate the rol...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858633/ https://www.ncbi.nlm.nih.gov/pubmed/33536442 http://dx.doi.org/10.1038/s41598-021-81959-1 |